drugset
drugset / Trial / NCT01721707

Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH

NCT01721707 ↗

Phase 3 Withdrawn Adapt Produtos Oftalmológicos Ltda.
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is a double-masked, randomized, parallel group study in patients with open angle glaucoma or ocular hypertension. The aim of this study is to verify the efficacy of the fixed combination of Latanoprost 50 mcg / mL / brinzolamide 10mg/ml eye drops compared to Latanoprost 50μg/mL eye drops in reducing IOP

Timeline

Start
2012-12
Primary completion
2013-03
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Brinzolamide Small molecule 1 % Other
Subject Brinzolamide Small molecule 10 mg/ml Other
Subject Latanoprost Small molecule 0.005 % Other
Subject Latanoprost Small molecule 50 mg/ml Other

Indications

ocular hypertension open-angle glaucoma